Christopher Simon - May 30, 2025 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role: President & CEO, Director
Signature: /s/ Thomas V. Powers, attorney-in-fact for Mr. Simon
Stock symbol: HAE
Transactions as of: May 30, 2025
Transactions value $: -$1,820,115
Form type: 4
Date filed: 6/3/2025, 04:41 PM
Previous filing: May 27, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Simon, Christopher	President & CEO, Director	125 SUMMER STREET, BOSTON	/s/ Thomas V. Powers, attorney-in-fact for Mr. Simon	2025-06-03	0001674993

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HAE	Common Stock	Award	$0	+66.7K	+19.89%	$0.00	402K	May 30, 2025	Direct	F1, F2
transaction	HAE	Common Stock	Tax liability	-$1.82M	-26.2K	-6.53%	$69.38	376K	May 30, 2025	Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on May 16, 2022, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 16, 2022 to May 15, 2025, as certified by the Compensation Committee of the Board of Directors on May 30, 2025.
F2	This number includes unvested restricted stock units ("RSUs") previously reported.
F3	Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I.